These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7152685)

  • 1. Antibiotic prophylaxis in gynecology: cefoxitin concentrations in serum, myometrium, endometrium and salpinges.
    Daschner F; Petersen E; Langmaack H; Trennhäuser M
    Infection; 1982; 10(6):341-2. PubMed ID: 7152685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic prevention in gynecology. Concentrations of ceftizoxime in the serum, myometrium, endometrium and fallopian tubes].
    Daschner F; Just HM; Brändle J; Zahn V
    Geburtshilfe Frauenheilkd; 1983 Nov; 43(11):683-5. PubMed ID: 6317510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue.
    Daschner FD; Petersen EE; Just HM; Hillemanns HG
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():247-9. PubMed ID: 6352627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of cefotetan into serum, myometrium, endometrium and salpinges.
    Just HM; Petersen EE; Bassler M; Frank U; Daschner FD
    Chemotherapy; 1984; 30(5):305-7. PubMed ID: 6593163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.
    Daschner FD; Petersen EE; Frank U; Hornig D
    Am J Med; 1984 Dec; 77(6A):4-6. PubMed ID: 6097123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease. Trovafloxacin Surgical Group.
    Roy S; Hemsell D; Gordon S; Godwin D; Pearlman M; Luke D
    Am J Surg; 1998 Dec; 176(6A Suppl):62S-66S. PubMed ID: 9935259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of cefotetan and cefoxitin in patients undergoing hysterectomies and colorectal operations.
    Quintiliani R; Nightingale CH; Stevens RC; Outman WR; Deckers PJ; Martens MG
    Am J Surg; 1988 May; 155(5A):67-70. PubMed ID: 3163902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a double-blind, placebo-controlled clinical trial program of single-dose ceftizoxime versus multiple-dose cefoxitin as prophylaxis for patients undergoing vaginal and abdominal hysterectomy.
    McGregor JA; Phillips LE; Roy S; Dunne JT; Warwaruk AS; Johnston DW; Yuzpe AA; Hemsell DL
    J Am Coll Surg; 1994 Feb; 178(2):123-31. PubMed ID: 8173721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefotetan and cefoxitin prophylaxis for abdominal and vaginal hysterectomy.
    Berkeley AS; Freedman KS; Ledger WJ; Orr JW; Benigno BB; Gordon SF; McGregor JA; Galask RP; Sevin BU
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):706-9. PubMed ID: 3128112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of cefmetazole or cefoxitin in the prevention of postoperative infection following vaginal and abdominal hysterectomy.
    Roy S; Wilkins J; Galaif E; Azen C
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():109-17. PubMed ID: 2656624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of two cephalosporins in the perioperative prophylaxis in patients undergoing abdominal or vaginal hysterectomies or gynaecological laparotomies: a prospective randomized study].
    Regidor PA; Bier UW; Preuss MJ; Eickhoff C; Hillger H; Kienle E; Schindler AE
    Gynakol Geburtshilfliche Rundsch; 2000; 40(3-4):153-8. PubMed ID: 11326160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cefoxitin for the prevention of postoperative infection in abdominal hysterectomy.
    Sutthijumroon S; Chandeying V; Tungphaisal S
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):347-51. PubMed ID: 2129189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental studies of cefoxitin in the field of obstetrics and gynecology].
    Ito K; Matsunami K; Hayasaki M; Noda K
    Jpn J Antibiot; 1985 Jan; 38(1):95-101. PubMed ID: 3989983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of ceftriaxone in serum and gynecological tissues.
    Daschner FD; Petersen EE; Brändle J; Hillemanns HG
    Chemotherapy; 1983; 29(2):153-5. PubMed ID: 6301774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomy.
    Berkeley AS; Orr JW; Cavanagh D; Freedman KS; Ledger WJ; Pastorek JG; Sevin BU
    Am J Surg; 1988 May; 155(5A):81-5. PubMed ID: 3287974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of multiple-dose cefoxitin vs. single-dose cefonicid for surgical prophylaxis in patients undergoing biliary tract operations or hysterectomy.
    Maki DG; Lammers JL; Aughey DR
    Rev Infect Dis; 1984; 6 Suppl 4():S887-95. PubMed ID: 6395279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy.
    Faro S; Pastorek JG; Aldridge KE; Nicaud S; Cunningham G
    Surg Gynecol Obstet; 1988 May; 166(5):431-5. PubMed ID: 3283973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of short-term versus long-term cefoxitin prophylaxis against postoperative infection after radical hysterectomy: a prospective study.
    Sevin BU; Ramos R; Gerhardt RT; Guerra L; Hilsenbeck S; Averette HE
    Obstet Gynecol; 1991 May; 77(5):729-34. PubMed ID: 2014087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophylaxis in vaginal hysterectomy.
    Rapp RP; Connors JE; Hager WD; Donaldson ES; van Nagell JR
    Clin Pharm; 1986 Dec; 5(12):988-93. PubMed ID: 3542346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.